4.8 Article

A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India

Journal

CIRCULATION
Volume 132, Issue 9, Pages 815-824

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.115.015373

Keywords

cardiovascular diseases; China; community; decision support techniques; India; prevention & control

Funding

  1. Federal funds from the US National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200900027C]
  2. UnitedHealth Group Chronic Disease Initiative
  3. National Natural Sciences Foundation of China [71110107025, 71233001, 71490732]
  4. US NIH R01 grant [R01AG023627]
  5. UNFPA
  6. National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services
  7. UnitedHealth Group, Minneapolis, MN, USA [HHSN268200900026C]
  8. Wellcome Trust Capacity Strengthening Strategic Award

Ask authors/readers for more resources

Background In rural areas in China and India, the cardiovascular disease burden is high but economic and healthcare resources are limited. This study (the Simplified Cardiovascular Management Study [SimCard]) aims to develop and evaluate a simplified cardiovascular management program delivered by community health workers with the aid of a smartphone-based electronic decision support system. Methods and Results The SimCard study was a yearlong cluster-randomized, controlled trial conducted in 47 villages (27 in China and 20 in India). Recruited for the study were 2086 individuals with high cardiovascular risk (aged 40 years with self-reported history of coronary heart disease, stroke, diabetes mellitus, and/or measured systolic blood pressure 160 mmHg). Participants in the intervention villages were managed by community health workers through an Android-powered app on a monthly basis focusing on 2 medication use and 2 lifestyle modifications. In comparison with the control group, the intervention group had a 25.5% (P<0.001) higher net increase in the primary outcome of the proportion of patient-reported antihypertensive medication use pre- and post-intervention. There were also significant differences in certain secondary outcomes: aspirin use (net difference: 17.1%; P<0.001) and systolic blood pressure (-2.7 mmHg; P=0.04). However, no significant changes were observed in the lifestyle factors. The intervention was culturally tailored, and country-specific results revealed important differences between the regions. Conclusions The results indicate that the simplified cardiovascular management program improved quality of primary care and clinical outcomes in resource-poor settings in China and India. Larger trials in more places are needed to ascertain the potential impacts on mortality and morbidity outcomes. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT01503814.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available